WENNY LEE: Open Payments
NPI 1730604364 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,921 in 34 payments from 14 companies in 2025. Trend: 2023 $257 · 2024 $507 · 2025 $2,921
Food & beverage: $2,921
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $774 |
| BeOne Medicines USA, Inc. | 4 | $286 |
| AstraZeneca Pharmaceuticals LP | 2 | $260 |
| Exelixis Inc. | 2 | $245 |
| Astellas Pharma US Inc | 2 | $242 |
| Janssen Biotech, Inc. | 2 | $240 |
| GlaxoSmithKline, LLC. | 2 | $229 |
| Ipsen Biopharmaceuticals, Inc | 5 | $206 |
| Incyte Corporation | 1 | $126 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $97 |
Products named: OPDIVO, TEVIMBRA, CABOMETYX, RYBREVANT, Onivyde, Jakafi, IMFINZI, Xtandi.
Industry payments across CA — which companies pay providers there.
